Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. (Q51556270)

7 April 2018

title

Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. (English)

1 reference

7 April 2018

main subject

pulmonary hypertension

1 reference

1 reference

Haraldsson A

1

1 reference

7 April 2018

Kieler-Jensen N

series ordinal

2

1 reference

7 April 2018

Ricksten SE

series ordinal

3

1 reference

7 April 2018

publication date

1 December 1996

1 reference

7 April 2018

Journal of Cardiothoracic and Vascular Anesthesia

published in

1 reference

7 April 2018

volume

10

1 reference

7 April 2018

page(s)

864-868

1 reference

7 April 2018

issue

7

1 reference

7 April 2018

Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Central hemodynamics and right ventricular function after coronary artery bypass surgery. A comparison of prostacyclin, sodium nitroprusside, and nitroglycerin for treatment of postcardiac surgical hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Maternal expectations and experiences of labour pain--options of 1091 Finnish parturients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Aerosolised prostacyclin in adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Prostaglandins: Their Disappearance from and Release into the Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Inactivation of Prostaglandins by the Lungs

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Aerosolized prostacyclin. In search of the ideal pulmonary vasodilator

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Pulmonary deposition of a nebulised aerosol during mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Down-regulation of endogenous nitric oxide production after prolonged administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980047-4

7 January 2021

10.1016/S1053-0770(96)80047-4

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

8969392

1 reference

7 April 2018